Venetoclax First Cycle Treatment in a Case of Severe AML FAB M2 and COVID-19 Pneumoniae: A Rare Clinical Scenario
Published: 2021-01-25
Page: 12-18
Issue: 2021 - Volume 4 [Issue 1]
Radu Gaba *
Institute of Math. of the Romanian Academy, RO-014700, Bucharest, Romania.
*Author to whom correspondence should be addressed.
Abstract
Here we describe a rare case of a venetoclax first cycle treatment in a case of a newly diagnosed COVID-19 pneumoniae.
Keywords: Post-covid syndrome, hemoptysis, thrombocytopenia, acute myeloid leukemia, SARS-CoV-2.